Bristol-Myers Squibb Stock Set To Outperform S&P 500 Post Coronavirus? |
March 13, 2020 | March 2020 Bond Updates |
Bristol-Myers Squibb (NYSE: BMY) could outperform the broader S&P 500 index, going by trends seen during the 2008 slowdown. It is likely that it could bounce back strongly from the recent lows of around $53 and potentially outperform, when the coronavirus and oil price war crisis winds down... |
View more at: https://www.forbes.com/sites/greatspeculations/2020/03/13/bristol-myers-squibb-stock-set-to-outperform-sp-500-post-coronavirus/ |
Related News |
|